Kaiser Health News |
Mylan's Generic EpiPen — A Price Break Or Marketing Maneuver?
Kaiser Health News Some called it a marketing ploy, while Robert Weissman, president of the consumer group Public Citizen, said the generic price was still too high, writing in the Huffington Post of “the weirdness of a drug company offering a generic version” of its own ... |
September 01, 2016 at 06:02AM | marketing - Google News
Mylan's Generic EpiPen — A Price Break Or Marketing Maneuver? - Kaiser Health News
marketing - Google News
Nenhum comentário:
Postar um comentário